Table of Contents

1 Market Overview
1.1 Amifostine Introduction
1.2 Market Analysis by Type
1.2.1 400mg/Dose
1.2.2 500mg/Dose
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer Adjuvant Therapy
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Clinigen Group
2.1.1 Business Overview
2.1.2 Amifostine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sun Pharmaceutical
2.2.1 Business Overview
2.2.2 Amifostine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Taj Pharmaceuticals
2.3.1 Business Overview
2.3.2 Amifostine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merro Pharmaceutical
2.4.1 Business Overview
2.4.2 Amifostine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Amifostine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mingren Pharma
2.6.1 Business Overview
2.6.2 Amifostine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Amifostine Market Competition, by Manufacturer
3.1 Global Amifostine Sales and Market Share by Manufacturer
3.2 Global Amifostine Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Amifostine Manufacturer Market Share
3.3.2 Top 6 Amifostine Manufacturer Market Share
3.4 Market Competition Trend
4 Global Amifostine Market Analysis by Regions
4.1 Global Amifostine Sales, Revenue and Market Share by Regions
4.1.1 Global Amifostine Sales by Regions (2012-2017)
4.1.2 Global Amifostine Revenue by Regions (2012-2017)
4.2 North America Amifostine Sales and Growth (2012-2017)
4.3 Europe Amifostine Sales and Growth (2012-2017)
4.4 Asia-Pacific Amifostine Sales and Growth (2012-2017)
4.5 South America Amifostine Sales and Growth (2012-2017)
4.6 Middle East and Africa Amifostine Sales and Growth (2012-2017)
5 North America Amifostine by Countries
5.1 North America Amifostine Sales, Revenue and Market Share by Countries
5.1.1 North America Amifostine Sales by Countries (2012-2017)
5.1.2 North America Amifostine Revenue by Countries (2012-2017)
5.2 USA Amifostine Sales and Growth (2012-2017)
5.3 Canada Amifostine Sales and Growth (2012-2017)
5.4 Mexico Amifostine Sales and Growth (2012-2017)
6 Europe Amifostine by Countries
6.1 Europe Amifostine Sales, Revenue and Market Share by Countries
6.1.1 Europe Amifostine Sales by Countries (2012-2017)
6.1.2 Europe Amifostine Revenue by Countries (2012-2017)
6.2 Germany Amifostine Sales and Growth (2012-2017)
6.3 UK Amifostine Sales and Growth (2012-2017)
6.4 France Amifostine Sales and Growth (2012-2017)
6.5 Russia Amifostine Sales and Growth (2012-2017)
6.6 Italy Amifostine Sales and Growth (2012-2017)
7 Asia-Pacific Amifostine by Countries
7.1 Asia-Pacific Amifostine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Amifostine Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Amifostine Revenue by Countries (2012-2017)
7.2 China Amifostine Sales and Growth (2012-2017)
7.3 Japan Amifostine Sales and Growth (2012-2017)
7.4 Korea Amifostine Sales and Growth (2012-2017)
7.5 India Amifostine Sales and Growth (2012-2017)
7.6 Southeast Asia Amifostine Sales and Growth (2012-2017)
8 South America Amifostine by Countries
8.1 South America Amifostine Sales, Revenue and Market Share by Countries
8.1.1 South America Amifostine Sales by Countries (2012-2017)
8.1.2 South America Amifostine Revenue by Countries (2012-2017)
8.2 Brazil Amifostine Sales and Growth (2012-2017)
8.3 Argentina Amifostine Sales and Growth (2012-2017)
8.4 Columbia Amifostine Sales and Growth (2012-2017)
9 Middle East and Africa Amifostine by Countries
9.1 Middle East and Africa Amifostine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Amifostine Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Amifostine Revenue by Countries (2012-2017)
9.2 Saudi Arabia Amifostine Sales and Growth (2012-2017)
9.3 UAE Amifostine Sales and Growth (2012-2017)
9.4 Egypt Amifostine Sales and Growth (2012-2017)
9.5 Nigeria Amifostine Sales and Growth (2012-2017)
9.6 South Africa Amifostine Sales and Growth (2012-2017)
10 Global Amifostine Market Segment by Type
10.1 Global Amifostine Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Amifostine Sales and Market Share by Type (2012-2017)
10.1.2 Global Amifostine Revenue and Market Share by Type (2012-2017)
10.2 400mg/Dose Sales Growth and Price
10.2.1 Global 400mg/Dose Sales Growth (2012-2017)
10.2.2 Global 400mg/Dose Price (2012-2017)
10.3 500mg/Dose Sales Growth and Price
10.3.1 Global 500mg/Dose Sales Growth (2012-2017)
10.3.2 Global 500mg/Dose Price (2012-2017)
11 Global Amifostine Market Segment by Application
11.1 Global Amifostine Sales Market Share by Application (2012-2017)
11.2 Ovarian Cancer Adjuvant Therapy Sales Growth (2012-2017)
11.3 Head and Neck Cancer Adjuvant Therapy Sales Growth (2012-2017)
11.4 Others Sales Growth (2012-2017)
12 Amifostine Market Forecast (2017-2022)
12.1 Global Amifostine Sales, Revenue and Growth Rate (2017-2022)
12.2 Amifostine Market Forecast by Regions (2017-2022)
12.2.1 North America Amifostine Market Forecast (2017-2022)
12.2.2 Europe Amifostine Market Forecast (2017-2022)
12.2.3 Asia-Pacific Amifostine Market Forecast (2017-2022)
12.2.4 South America Amifostine Market Forecast (2017-2022)
12.2.5 Middle East and Africa Amifostine Market Forecast (2017-2022)
12.3 Amifostine Market Forecast by Type (2017-2022)
12.4 Amifostine Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source